A University of Saskatchewan research team led by Tony Kusalik and Scott Napper has harnessed bioinformatics and molecular biology to create powerful software that promises to become a "must have" tool in drug development research labs the world over.
The software is used to analyze kinases a type of enzyme involved in virtually every cellular function, from energy use and reproduction to modifying gene expression. Licensing of the patented technology is currently underway, and a demonstration of its effectiveness recently appeared in the journal Science Signalling.
"This is a premiere example of what can be achieved through interdisciplinary and collaborative research," says Kusalik, a professor in the computer science department.
Kinases are often involved in cellular functions that go awry, such as when pathogens like viruses or bacteria "hijack" a cell's functions for their own purposes. Pathogens also have kinases of their own.
"Kinases have a central role in controlling cellular processes and are associated with many diseases. They're logical points for understanding biology and represent important treatment targets," says Napper, an associate professor of biochemistry with the U of S and senior scientist at the Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac).
The standard lab tool in kinase research is the microarray, which allows researchers to analyze many different kinases within a sample simultaneously. A microarray looks like a standard microscope slide with rows of spots, each spot representing a different molecular test.
"With older methods, it was like having a little flashlight in a cave you can see, but it doesn't tell you all that is there," Napper says. "These arrays give you the whole picture but you end up with absolutely mountains of data."
The problem for Napper and fellow VIDO-InterVac senior scientist Philip Griebel was t
|Contact: Michael Robin|
University of Saskatchewan